Abstract

BackgroundMedication-assisted treatment (MAT) remains the gold standard for the treatment of opioid use disorder. MAT also reduces the frequency of injecting among people who inject drugs (PWID). Relatedly, data suggest that PWID play a key role in the initiation of others into drug injecting by exposing injecting practices to injection-naïve drug users. Our primary objective was to test whether a history of MAT enrollment is associated with a reduced odds of PWID providing injection initiation assistance.MethodsPreventing Injecting by Modifying Existing Responses (PRIMER; NIDA DP2-DA040256–01), is a multi-site cohort study assessing the impact of socio-structural factors on the risk that PWID provide injection initiation assistance. Data were drawn from a participating cohort of PWID in San Diego, CA. The primary outcome was reporting ever providing injection initiation assistance; the primary predictor was reporting ever being enrolled in MAT. Logistic regression was used to model associations between MAT enrollment and ever initiating others into injecting while adjusting for potential confounders.ResultsParticipants (n = 354) were predominantly male (n = 249, 70%). Thirty-eight percent (n = 135) of participants reported ever initiating others into injection drug use. In multivariate analysis, participants who reported a history of MAT enrollment had significantly decreased odds of ever providing injection initiation assistance (Adjusted Odds Ratio [AOR]: 0.62, 95% Confidence Interval [CI]: 0.39–0.99).ConclusionsThese preliminary findings suggest an association between MAT enrollment and a lower odds that male PWID report providing injection initiation assistance to injection-naïve drug users. Further research is needed to identify the pathways by which MAT enrollment may impact the risk that PWID initiate others into drug injecting.

Highlights

  • Medication-assisted treatment (MAT) remains the gold standard for the treatment of opioid use disorder

  • Given that MAT is associated with reductions in the frequency of opioid injecting among people who inject drugs (PWID) as well as street-based injecting in particular, we hypothesize that MAT enrollment may have a secondary preventive impact on the risk that PWID expose and initiate others into injecting [3,4,5,6,7,8,9,10]

  • PWID reporting a history of MAT enrollment had significantly decreased odds of initiating others into injecting (Wald χ2 = 4.04, df = 1, p = 0.04; see Table 2)

Read more

Summary

Introduction

Medication-assisted treatment (MAT) remains the gold standard for the treatment of opioid use disorder. Medication-assisted treatment (MAT) remains the gold standard of biomedical care for opioid use disorder, and is effective in reducing the frequency of injecting among people who inject drugs (PWID) [1,2,3,4]. This is important given the growing scientific consensus that PWID play a key role in the expansion of injection-related.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call